₹ 115200
₹68- ₹72
1600
₹75
4
24 Jun 2025
Download26 Jun 2025
27 Jun 2025
Application Details
Aakaar Medical Technologies IPO is a bookbuilding of ₹27.00 crores. The issue is entirely a fresh issue of 37.50 lakh shares.
Aakaar Medical Technologies IPO bidding opened for subscription on June 20, 2025 and will close on June 24, 2025. The allotment for the Aakaar Medical Technologies IPO is expected to be finalized on Wednesday, June 25, 2025. Aakaar Medical Technologies IPO will be list on NSE SME with a tentative listing date fixed as Friday, June 27, 2025.
Aakaar Medical Technologies IPO price band is set at ₹68 to ₹72 per share. The minimum lot size for an application is 1600. The minimum amount of investment required by retail investors is ₹1,08,800. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹1,15,200. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹2,30,400.
About Aakaar Medical Technologies Limited (SME IPO)
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company specializing in a wide range of cosmetic products and devices. The company caters primarily to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists, offering both domestically manufactured and internationally sourced products.
Its portfolio includes in-house brands and imported products from countries such as South Korea, Spain, Italy, and Austria. Aakaar supplies these offerings to medical professionals, who then either use them in treatments or provide them to end consumers. The product range covers homecare and professional skincare, injectable and contouring solutions, hair care products including serums and anti-hair loss tablets, medifacial kits, and advanced devices for treatments such as laser hair reduction, skin rejuvenation, pigmentation correction, tattoo removal, hair transplantation, and urinary incontinence management.
FAQ
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.